KLH Preparation methods for a novel generation of biological safe KLH Products used for cancer treatment for the development of conjugated therapeutic vaccines and as challenging agents
The present invention relates to the provision of biologically safe hematopoietic serum, preferably hemopoietic, more preferably KLH (non-keyhole limpet hemocyanin). There is provided a method for producing a virus-free hemocyanin.본 발명은 생물학적으로 안전한 혈림프 혈청, 바람직하게는 헤모시아닌, 더욱 바람직하게는 KLH (키홀 림펫 헤모시아닌)의 제공에 관한 것이다. 바이러스가 없는 헤모시아닌을 제조하는 방법이 제공된다.